SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag166
David Wang, Brendon J Yee, Ronald R Grunstein
{"title":"Psychomotor vigilance test correlates with obstructive sleep apnea-related current sleepiness and EEG activation.","authors":"David Wang, Brendon J Yee, Ronald R Grunstein","doi":"10.1093/sleep/zsag166","DOIUrl":"10.1093/sleep/zsag166","url":null,"abstract":"","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148278895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag164
Sullafa Kadura, Samia H Lopa, Mark Oldham, Lisa Pink, Diego R Mazzotti, Sanjay R Patel
{"title":"Defining the hospital night: deriving and validating electronic health record-based measures of the inpatient sleep experience.","authors":"Sullafa Kadura, Samia H Lopa, Mark Oldham, Lisa Pink, Diego R Mazzotti, Sanjay R Patel","doi":"10.1093/sleep/zsag164","DOIUrl":"10.1093/sleep/zsag164","url":null,"abstract":"<p><strong>Study objectives: </strong>To identify electronic health record (EHR)-derived sleep measures associated with the inpatient sleep experience during hospitalization.</p><p><strong>Methods: </strong>We recruited 247 inpatients who completed the Karolinska Sleep Diary and the Potential Hospital Sleep Disruptions and Noise Questionnaire. Using EHR data, we derived three measures: longest uninterrupted sleep opportunity (LUSO), total uninterrupted sleep opportunity (TUSO), and patient-staff interactions (PSIs) calculated within two timeframes: a fixed window (23:00-06:00) and a patient-defined window (lights out to final awakening). We examined the associations between EHR-derived measures calculated within each window and sleep experience measures.</p><p><strong>Results: </strong>Sleep duration correlated more strongly with patient-defined TUSO (r = 0.63, p < .001) than with fixed TUSO (r = 0.27, p < .001). Ratings of sleep continuity, refreshing sleep, and sound sleep were also associated with patient-defined TUSO (TUSO r = 0.15-0.23; all p < .05), supporting its construct validity as an indicator of sleep quality. Sleep disruption ratings were associated with EHR-derived measures of overnight activity, including PSI counts (r = 0.35 within fixed windows vs. r = 0.29 within patient-defined windows; both p < .001).</p><p><strong>Conclusions: </strong>EHR-derived measures of sleep opportunity and interruption provide scalable tools for characterizing the inpatient sleep experience using routinely collected clinical data. Measures calculated within patient-defined windows show stronger associations with sleep duration and quality, while PSIs calculated within both window types show similar associations with perceived sleep disruption from overnight clinical workflows. These complementary approaches may inform strategies to reduce unnecessary nighttime disturbances and improve sleep in hospitalized patients. Statement of Significance Poor sleep is a near-universal complaint among hospitalized patients, yet methods for measuring inpatient sleep remain limited. Our study demonstrates that measures of sleep opportunity and disruption can be derived from routinely documented data in the electronic health record (EHR). Measures calculated within patient-defined sleep windows show stronger alignment with sleep duration and quality, whereas measures derived from both patient-defined and fixed workflow-defined windows capture sleep disruption associated with patient-staff interactions. Knowledge gaps remain in determining how these measures relate to patient recovery, safety, and satisfaction. Future work should investigate how EHR-based sleep measures can be leveraged to facilitate system-level interventions aimed at improving sleep in hospital settings.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148259617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correlation of hypoxic burden with blood pressure diurnal rhythm in obstructive sleep apnea.","authors":"Qianqian Wang, Xiaoxin Lan, Zhengjiao Zhang, Xuefeng Song, Songyu Wu, Yanzhao Dong, Siqi Jia, Haibo Yuan","doi":"10.1093/sleep/zsag167","DOIUrl":"10.1093/sleep/zsag167","url":null,"abstract":"<p><strong>Study objectives: </strong>Obstructive sleep apnea is associated with disturbances in blood pressure patterns, which is recognized as an independent cardiovascular risk factor. However, conventional hypoxic indicators of obstructive sleep apnea severity showed inconsistent associations with these blood pressure disturbances. Hypoxic burden, a metric integrating the frequency, depth, and duration of desaturation, may better represent the characteristics of hypoxia. We hypothesized that hypoxic burden would be more closely associated with blood pressure patterns compared to other traditional hypoxia indicators.</p><p><strong>Materials and methods: </strong>Hypoxic burden was measured from polysomnography, followed by 24-h ambulatory blood pressure monitoring in 377 patients with suspected obstructive sleep apnea. Patients were grouped based on the rhythms of systolic blood pressure and diastolic blood pressure. Logistic regression analysis was conducted to assess the association between hypoxic burden and blood pressure rhythm impairment.</p><p><strong>Results: </strong>Hypoxic burden was significantly higher in the non-dipper groups than that in the dipper groups. After adjusting for various confounders, subjects with higher hypoxic burden in the fourth quartile were more likely to exhibit systolic blood pressure non-dipping pattern in model 3. Similarly, the association between hypoxic burden and nocturnal hypertension also remained statistically significant after adjusting for all the confounding factors. However, none of the conventional hypoxic metrics were consistently associated with blood pressure rhythm abnormalities after adjusting for various confounders.</p><p><strong>Conclusions: </strong>Compared to conventional polysomnography hypoxic parameters, hypoxic burden is more closely associated with circadian systolic blood pressure rhythm and nocturnal hypertension in obstructive sleep apnea. Hypoxic burden may be a promising indicator for guiding early intervention in high-risk obstructive sleep apnea patients and predicting adverse cardiovascular outcomes.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148309585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag191
Henna Pitkänen, Riku Huttunen, Masoumeh Tashakori, Marika Rissanen, Matias Rusanen, Heidur Gretarsdottir, Erna Sif Arnardottir, Tiina Paunio, Antti Kulkas, Sami Nikkonen, Timo Leppänen, Henri Korkalainen
{"title":"Automated deep learning-based arousal detection agrees with ten expert scorers in unseen data.","authors":"Henna Pitkänen, Riku Huttunen, Masoumeh Tashakori, Marika Rissanen, Matias Rusanen, Heidur Gretarsdottir, Erna Sif Arnardottir, Tiina Paunio, Antti Kulkas, Sami Nikkonen, Timo Leppänen, Henri Korkalainen","doi":"10.1093/sleep/zsag191","DOIUrl":"10.1093/sleep/zsag191","url":null,"abstract":"<p><strong>Study objectives: </strong>Automatic arousal scoring is essential for the cost-effective analysis of polysomnograms. Many previous automatic methods have been tested in homogeneous, single-center datasets, and all against one scorer, on event-by-event basis, or in 30-s segments. We developed a deep learning-based arousal scoring model and tested it at 1-s resolution in an independent dataset scored by ten expert scorers from seven different sleep centers.</p><p><strong>Materials and methods: </strong>A fully convolutional neural network model was developed using 1847 openly available polysomnograms from the Multi-Ethnic Study of Atherosclerosis (MESA) and tested in 205 hold-out polysomnograms from the MESA cohort, and in an independent Sleep Revolution (SR) cohort of 50 polysomnograms, each scored by ten scorers. Model performance was evaluated on an event-by-event basis and in 1-s segments. In the SR dataset, the performance was tested against each scorer individually and against their majority agreement.</p><p><strong>Results: </strong>In the MESA test set, the model achieved an event-by-event F1-score of 0.77, a 1-s segment κ-value of 0.67, and an arousal index (ArI) intraclass correlation coefficient (ICC) of 0.83. In the multi-scorer SR dataset, the model reached a median event-by-event F1-score, a 1-s κ-value, and an ArI ICC of 0.61, 0.50, and 0.66, respectively, exceeding the corresponding median values of the scorers among themselves (0.57, 0.46, and 0.59, respectively).</p><p><strong>Conclusions: </strong>The model achieved higher median arousal scoring agreement with ten manual scorers than the scorers did among themselves in an independent dataset. This suggests that the model generalizes well and can reliably be used in different sleep recordings.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148473020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag184
Chisom Kanu, Shraddha Shinde, Beverly Falcon, Josef Bednarik, Cathy Chang Xie, Kevin Trice, Terri Weaver
{"title":"Changes in patient-reported outcomes and objective assessments based on baseline symptom severity in SURMOUNT-OSA: post-hoc analyses.","authors":"Chisom Kanu, Shraddha Shinde, Beverly Falcon, Josef Bednarik, Cathy Chang Xie, Kevin Trice, Terri Weaver","doi":"10.1093/sleep/zsag184","DOIUrl":"10.1093/sleep/zsag184","url":null,"abstract":"<p><strong>Study objectives: </strong>These post-hoc analyses of SURMOUNT-OSA evaluated patient-reported outcome measures (PROMs) and objective assessments, considering participants' baseline characterization of fatigue, sleepiness, snoring, and sleep quality.</p><p><strong>Materials and methods: </strong>SURMOUNT-OSA included two 52-week randomized, placebo-controlled studies of tirzepatide (10/15 mg) in participants with moderate-to-severe obstructive sleep apnea (OSA) and obesity (Study 1: participants not using positive airway pressure [PAP]; Study 2: participants using PAP). Participants were grouped by self-reported baseline severity of fatigue (Non-fatigued/Fatigued), sleepiness (Non-sleepy/Sleepy), snoring (Non-snoring/Snoring), and sleep quality (Good/Poor). Changes in PROMs and objective assessments from baseline to Week 52 were assessed per subgroup.</p><p><strong>Results: </strong>In both studies, tirzepatide treatment was consistently associated with greater improvements in PROMs and objective assessments than placebo. In Study 1, tirzepatide-treated participants in the Fatigued subgroup had numerically greater improvements versus Non-fatigued subgroup in Functional Outcomes of Sleep Questionnaire Activity Level (least-square means [LSM] difference from placebo: 0.33 vs. 0.05), SF-36v2 Vitality, (8.5 vs. 1.0), and SF-36v2 General Health scores (6.2 vs. 1.4). The Sleepy subgroup showed numerically greater improvements versus Non-sleepy subgroup in Patient-Reported Outcomes Measurement Information System (PROMIS) Short-Form Sleep-Related Impairment 8a scores (LSM difference: -7.1 vs. -1.6) while the Poor sleep quality subgroup had numerically greater improvements versus Good sleep quality subgroup in PROMIS Short-Form Sleep Disturbance scores (LSM difference: -5.8 vs. -1.2). Changes in PROMs were similar in both snoring subgroups. Study 2 patterns were generally consistent with Study 1. Tirzepatide treatment was associated with similar improvements in objective assessments (apnea-hypopnea index, sleep apnea-specific hypoxic burden, weight, OSA remission) across all symptom severity subgroups in both studies.</p><p><strong>Conclusions: </strong>Across subgroups, tirzepatide treatment was associated with greater improvements in PROMs than placebo. Participants with worse fatigue, sleepiness, and sleep quality at baseline generally had larger improvements on related PROMs than those with milder symptoms. Tirzepatide treatment was also associated with greater improvements in objective assessments versus placebo, though these changes were generally similar across baseline symptom severity subgroups.</p><p><strong>Clinical trial registration: </strong>Registered at ClinicalTrials.gov under \"Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea (SURMOUNT-OSA)\"; https://clinicaltrials.gov/study/NCT05412004; registration number: NCT05412004.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148405982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag163
Jack T Jagielski, Makayla R Kelleher, Emma P Strainis, Olivia A Cesarone, Laurene Leclair-Visonneau, Thomas J Finstuen, Stuart J McCarter, Megan J Broeren, Rene L Utianski, Farwa Ali, Diego Z Carvalho, Bradley F Boeve, Michael H Silber, Hugo Botha, Jennifer L Whitwell, Keith A Josephs, E K St Louis
{"title":"Characterization of sleep disturbances in primary progressive apraxia of speech.","authors":"Jack T Jagielski, Makayla R Kelleher, Emma P Strainis, Olivia A Cesarone, Laurene Leclair-Visonneau, Thomas J Finstuen, Stuart J McCarter, Megan J Broeren, Rene L Utianski, Farwa Ali, Diego Z Carvalho, Bradley F Boeve, Michael H Silber, Hugo Botha, Jennifer L Whitwell, Keith A Josephs, E K St Louis","doi":"10.1093/sleep/zsag163","DOIUrl":"10.1093/sleep/zsag163","url":null,"abstract":"","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148607767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag088
Tianshu Hou, Zhen Deng
{"title":"Pragmatic support or electronic nicotine delivery systems effect? Interpreting sleep outcomes in a smoking-cessation trial.","authors":"Tianshu Hou, Zhen Deng","doi":"10.1093/sleep/zsag088","DOIUrl":"10.1093/sleep/zsag088","url":null,"abstract":"","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147618415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag115
Elena S Wenz, Jean-Christophe Prost, Sophie Braga-Lagache, Gabriela M Mäder, Jan D Warncke, Martin Luginbühl, Patrick Y Wuethrich, Friedrich Lersch, Christoph Schankin, Irina Filchenko, Livia Fregolente, Kseniia Zub, Seiji Nishino, Carlo R Largiadèr, Manfred Heller, Mehdi Tafti, Markus H Schmidt, Claudio L A Bassetti
{"title":"Hypocretin-1/orexin-A fragment1-16 as a potential surrogate marker for diagnosing narcolepsy type 1.","authors":"Elena S Wenz, Jean-Christophe Prost, Sophie Braga-Lagache, Gabriela M Mäder, Jan D Warncke, Martin Luginbühl, Patrick Y Wuethrich, Friedrich Lersch, Christoph Schankin, Irina Filchenko, Livia Fregolente, Kseniia Zub, Seiji Nishino, Carlo R Largiadèr, Manfred Heller, Mehdi Tafti, Markus H Schmidt, Claudio L A Bassetti","doi":"10.1093/sleep/zsag115","DOIUrl":"10.1093/sleep/zsag115","url":null,"abstract":"<p><strong>Study objectives: </strong>Loss of cerebrospinal fluid (CSF) hypocretin-1/orexin-A (Hcrt-1) immunoreactivity is a biomarker for narcolepsy type 1 (NT1). The current radioimmunoassay (RIA) does not allow precise quantification, limiting the assessment of disease severity and evolution. This study aimed to reproduce previously proposed workflows to quantify Hcrt-1 and Hcrt-2 by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS), identify RIA antibody targets, and to compare two purification methods in their ability to identify patients with NT1.</p><p><strong>Methods: </strong>Solid phase extraction (SPE) and LC-MS/MS measurements of Hcrt-1 and -2 levels from 10 NT1 patients and 21 controls were implemented based on existing literature. Immunoprecipitation (IP) with magnetic beads coupled to the RIA antibody (Phoenix) was performed and peptides identified by MS. Finally, Hcrt-1 (full-length) and Hcrt-1 fragment1-16 levels were analyzed in 4 patients and 4 controls prepared from both workflows by nano-LC coupled to high-resolution mass spectrometry.</p><p><strong>Results: </strong>Despite linear calibration curves for Hcrt-1 and Hcrt-2 (R2 > 0.99) could be assessed with LC-MS/MS, full-length Hcrt-1 concentrations were at the low end of the calibration curve with slightly lower levels in NT1 (p = 0.04). Hcrt-2 was undetectable. The discovery experiment with IP most reliably identified Hcrt-1 fragment1-16. SPE revealed much higher concentrations than IP. Hcrt-11-16-levels allowed distinguishing patients and controls after SPE and IP, whereas full-length Hcrt-1-levels after IP did not.</p><p><strong>Conclusions: </strong>Hcrt-11-16 appears stable and abundant in CSF of controls, allows identification of patients with NT1 and is a promising surrogate marker. SPE seems more suitable for further method validation in clinical routine. Statement of Significance This proof-of-concept study is a systematic approach to the mass-spectrometric quantification of the neuropeptide hypocretin-1/orexin-A (Hcrt-1) in the cerebrospinal fluid, since the currently used radioimmunoassay (RIA) does not allow precise quantification. It reveals Hcrt-1 N-terminal derived fragment1-16 as one main target of the RIA-antibody, and strengthens its potential role as a new surrogate marker for Hcrt-1 for targeted quantification. Hcrt-11-16 is significantly reduced in patients with narcolepsy type 1 and appears to serve as a possible marker to discriminate NT1 from controls using two different purification methods, prior to measurements by nano-liquid chromatography coupled to high resolution mass spectrometry. Findings will need replication in a larger and more diverse cohort, including patients with different central disorders of hypersomnolence and intermediate RIA measured hypocretin levels to further determine their clinical significance.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147949474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-13DOI: 10.1093/sleep/zsag180
Emily Schlafly, Marta Karas, Yishu Gong, Lucie Barateau, Brian Tracey, Dmitri Volfson, Yves Dauvilliers
{"title":"Nocturnal features and daytime characteristics in narcolepsy: reliability and diagnostic relevance for NT1 Versus NT2.","authors":"Emily Schlafly, Marta Karas, Yishu Gong, Lucie Barateau, Brian Tracey, Dmitri Volfson, Yves Dauvilliers","doi":"10.1093/sleep/zsag180","DOIUrl":"10.1093/sleep/zsag180","url":null,"abstract":"<p><strong>Study objectives: </strong>Assess test-retest reliability of nighttime sleep and daytime maintenance of wakefulness tests (MWTs) over a short time interval in drug-free individuals with narcolepsy; evaluate the diagnostic utility of features with good reliability.</p><p><strong>Methods: </strong>We analyzed the placebo arms from clinical trials in narcolepsy type 1 (NT1; n = 17; NCT05687903) and narcolepsy type 2 (NT2; n = 19; NCT05687916). Participants visited the clinic three times, four weeks apart, which included nocturnal polysomnography (nPSG) and MWT the following day. From the nPSG and daytime MWT, we derived 440 features and assessed test-retest reliability, visit effects, and NT1-NT2 differences.</p><p><strong>Results: </strong>Quantitative electroencephalography (qEEG) showed high reliability, with the top 10 features showing reliability >0.88; the 10 most reliable hypnogram features ranged from 0.68-0.78. qEEG and MWT sleep onset latencies (SOLs) were less reliable in NT2. N1 percentage, stage shift index, and wake after sleep onset were reliable and differed between diagnoses (r = 0.54-0.75; higher in NT1, p < .05). MWT SOLs at 2 p.m. and 4 p.m. demonstrated good reliability in NT1 (r = 0.89, 0.87) and differed between diagnoses (shorter in NT1; p = .037, .010). Hypnodensity Wake-REM mixtures were reliable (r = 0.83) and differed between diagnoses (higher in NT1, p = .001).</p><p><strong>Conclusions: </strong>qEEG features showed the strongest reliability but rarely distinguished diagnoses. Measures of sleep fragmentation and wakefulness reliably differentiated NT1 from NT2 and are practical for clinical assessments and trials. Hypnodensity features, though not yet used clinically, are reliable and may offer diagnostic value. NT2 exhibited greater variability in nighttime sleep and daytime wakefulness across visits.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13658287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148405997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}